Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study

References

• Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Prac Res Clin Haematol. 2011;24:59–64.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–36.
   PubMed Web of Science ®Google Scholar
• Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, Strazzer S . Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127:2518–32.
   PubMed Web of Science ®Google Scholar
• Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, . Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008;31:395–5.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, . Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci. 2008;265:78–83.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, . Mesenchymal stem cell transplantation i n amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol. 2010;223:229–37.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, . Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res. 2006;28:523–6.
   PubMed Web of Science ®Google Scholar
• Appel SH, Engelhardt JI, Henkel JS, Siklos L, Beers DR, Yen AA, . Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 2008; 71:1326–34.
   PubMed Web of Science ®Google Scholar
• Blanquer M, Perez-Espejo MA, Martinez-Lage JF, Iniesta F, Martinez S, Moraleda JM. A surgical technique of spinal cord cell transplantation in amyotrophic lateral sclerosis. J Neurosci Meth. 2010;191:255–7.
   PubMed Web of Science ®Google Scholar
• Deda H, Inci MC, Kurekci AE, Sav A, Kayihan K, Ozgun E, . Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11: 18–25.
   PubMed Web of Science ®Google Scholar
• Huang H, Chen L, Xi H, Wang H, Zhang J, Zhang F, . Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant. 2008;22:710–8.
   PubMed Web of Science ®Google Scholar
• Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, . Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010;67:1187–94.
   PubMed Web of Science ®Google Scholar
• Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E, Segura JJ. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy. 2009;11:26–34.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Vercelli A, Ferrero I, Mareschi K, Boido M, Servo S, . Stem cells in amyotrophic lateral sclerosis: state of the art. Expert Opin Biol Ther. 2009;9:1245–58.
   PubMed Web of Science ®Google Scholar
• Rosland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, . Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009;69: 5331–9.
   PubMed Web of Science ®Google Scholar
• Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, . Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035–9.
   PubMed Web of Science ®Google Scholar
• Garcia S, Bernad A, Martin MC, Cigudosa JC, Garcia-Castro J, de la Fuente R. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res. 2010; 316:1648–50.
   PubMed Web of Science ®Google Scholar
• Torsvik A, Rosland GV, Svendsen A, Molven A, Immervoll H, McCormack E, . Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track. Letter. Cancer Res. 2010;70:6393–6.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, . Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007;67:9142–9.
   PubMed Web of Science ®Google Scholar
• Kim J, Kang JW, Park JH, Choi Y, Choi KS, Park KD, . Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res. 2009;32:117–26.
   PubMed Web of Science ®Google Scholar
• Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, . Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood. 2010;115:1549–53.
   PubMed Web of Science ®Google Scholar
• Ferrero I, Mazzini L, Rustichelli D, Gunetti M, Mareschi K, Testa L, . Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant. 2008;17:255–66.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009 Feb 3;4:3.
   PubMed Web of Science ®Google Scholar
• Raore B, Federici T, Taub J, Wu MC, Riley J, Franz CK, . Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Spine (Phila Pa 1976). 2011;36:E164–71.
   PubMed Web of Science ®Google Scholar